Stocks
Integra LifeSciences Holdings Corporation (IART) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 15.2% | 19.5% | 23.7% | 25.1% | 24.9% | 14.9% | ||
| Changes by years, y/y, % | +5pp | +4pp | +4pp | +1pp | 0pp | +20.7% | |||
Integra LifeSciences Holdings Corporation. EBITDA margin, %
Integra LifeSciences Holdings Corporation. EBITDA margin, changes, pp
Integra LifeSciences Holdings Corporation (IART) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | 22.9% | 19.7% | 19.3% | 10.8% | 10.3% | 14.9% | |
| Changes by years, y/y, % | -3pp | -1pp | +7pp | +6pp | -13pp | |||
| Changes by quarters, q/q, % | +18pp | -3pp | 0pp | -8pp | -1pp | |||
